These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33681364)

  • 1. Identification of Tumor Tissue of Origin with RNA-Seq Data and Using Gradient Boosting Strategy.
    Li R; Liao B; Wang B; Dai C; Liang X; Tian G; Wu F
    Biomed Res Int; 2021; 2021():6653793. PubMed ID: 33681364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Machine Learning Method to Trace Cancer Primary Lesion Using Microarray-Based Gene Expression Data.
    Lu Q; Chen F; Li Q; Chen L; Tong L; Tian G; Zhou X
    Front Oncol; 2022; 12():832567. PubMed ID: 35530331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
    Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
    Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
    Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
    Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-cohort computational framework to trace tumor tissue-of-origin based on RNA sequencing.
    He B; Sun H; Bao M; Li H; He J; Tian G; Wang B
    Sci Rep; 2023 Sep; 13(1):15356. PubMed ID: 37717102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression.
    He B; Lang J; Wang B; Liu X; Lu Q; He J; Gao W; Bing P; Tian G; Yang J
    Front Bioeng Biotechnol; 2020; 8():394. PubMed ID: 32509741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
    Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
    Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.
    Miao Y; Zhang X; Chen S; Zhou W; Xu D; Shi X; Li J; Tu J; Yuan X; Lv K; Tian G
    Front Oncol; 2022; 12():946552. PubMed ID: 36016607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of 12 immune-related genes as a prognostic signature for colon adenocarcinoma.
    Tang D; Huang W; Yang Z; Wu X; Sang X; Wang K; Cao G
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22852. PubMed ID: 34396630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data.
    He B; Zhang Y; Zhou Z; Wang B; Liang Y; Lang J; Lin H; Bing P; Yu L; Sun D; Luo H; Yang J; Tian G
    Front Bioeng Biotechnol; 2020; 8():737. PubMed ID: 32850691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
    Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
    BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues.
    Bartha Á; Győrffy B
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas.
    Hargadon KM; Győrffy B; Strong EW
    Cancer Genet; 2021 Jun; 254-255():58-64. PubMed ID: 33636524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment.
    Wang C; He Y; Zheng J; Wang X; Chen S
    Front Immunol; 2023; 14():1130513. PubMed ID: 37153569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation.
    Raghu A; Raghu A; Wise JF
    JMIR Bioinform Biotechnol; 2024 Jul; 5():e56538. PubMed ID: 39046787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.